$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
NCCN将Tafasitamab-cxix联合来那度胺列入B细胞淋巴瘤治疗指南
2025-10-19 11:44:20
Check Details
英国指南推荐弥漫性大B细胞淋巴瘤新方案
2025-10-19 11:44:20
Check Details
Volibris多少钱一盒?
2025-10-19 11:44:20
Check Details
释倍灵纳入医保目录了吗?
2025-10-19 11:44:20
Check Details
释倍灵注意事项有哪些呢?
2025-10-19 11:44:20
Check Details
释倍灵目前已知获批适应症有哪些?
2025-10-19 11:44:20
Check Details
释倍灵(普乐沙福)的说明书
2025-10-19 11:44:20
Check Details
释倍灵医保能给予报销吗
2025-10-19 11:44:20
Check Details
释倍灵中国上市时间
2025-10-19 11:44:20
Check Details
释倍灵上市没?
2025-10-19 11:44:20
Check Details
释倍灵2020年的价格
2025-10-19 11:44:20
Check Details
释倍灵国内售价多少呢?
2025-10-19 11:44:20
Check Details
1
2
...
7272
7273
7274
7275
7276
7277
7278
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Etrasimod (Velsipity™): A Selective S1P Modulator Transforming Ulcerative Colitis Treatment
2
Delgocitinib Cream for Vitiligo: Mechanism, Potential, and Current Evidence
3
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
4
ROS and Cancer: The Potential of Natural Antioxidants
5
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
6
Breaking the Bottleneck: KOSELUGO® (Selumetinib) Reshapes the Treatment Landscape for Neurofibromatosis Type 1 (NF1)
7
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
8
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
9
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
10
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
11
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
12
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma